SavedAdd your journal

Journals / Maltepe Tıp Dergisi / 2016 / Cilt: 8 - Sayı: 3

Epigenetic Mechanisms and Hepatocellular Carcinoma

Epigenetik Mekanizmalar ve Hepatosellüler Karsinoma

Rumeysa DOĞAN
Ranan Gülhan AKTAŞ
Pages
29–35
Publication Date
2016-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the results of recent studies related with epigenetic mechanisms in the development of hepatocellular carcinoma have been summarized.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Epigenetic mechanisms provide heritable changes in gene expression and chromatin organization in the eukaryotic cells.
📊
Key Findings & Data:Abnormal epigenetic mechanisms particularly play a key role in many different diseases, such as hepatocellular carcinoma.
💡
Conclusion & Impact:In this review, the results of recent studies related with epigenetic mechanisms in the development of hepatocellular carcinoma have been summarized.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Hepatosellüler Karsinoma HCC · epigenetik mekanizmalar · miRNA

Abstract

Epigenetic mechanisms provide heritable changes in gene expression and chromatin organization in the eukaryotic cells. Abnormal epigenetic mechanisms particularly play a key role in many different diseases, such as hepatocellular carcinoma. Hepatocellular carcinoma HCC is both genetic and epigenetic disease and is located in the third place in cancer related deaths worldwide. Hepatocarcinogenesis is constituted by a complex, multistep process. Epigenetic changes include aberrant DNA methylation, posttranslational histone modifications, aberrant expression of non-coding RNAs such as miRNAs, lnc-RNAs and chromatin remodeling. These mechanisms can affect directly the expression of oncogenes, tumor suppressor genes and other tumor-related genes and alter the pathways in cancer development. Many complex deregulation of miRNAs, lnc-RNAs long non-coding RNAs and piRNAs PIWI-interacting RNAs are dramatically involved in hepatocarcinogenesis, which target tumor suppressor genes. Furthermore, down-regulation of these genes in HCC is induced by promoter hypermethylation or posttranslational deregulation. The role of these epigenetic mechanisms in hepatocarcinogenesis provide new therapeutic approaches for HCC. In this review, the results of recent studies related with epigenetic mechanisms in the development of hepatocellular carcinoma have been summarized.

Özet

Epigenetik mekanizmalar ökaryotik hücrelerde gen ekspresyonunda ve kromatin organizasyonunda kalıtımsal değişiklikler sağlamaktadır. Epigenetik mekanizmalardaki değişimler; hepatosellüler karsinoma ve diğer birçok hastalıkta önemli rol oynamaktadır. Hepatosellüler karsinoma HCC hem genetik hem de epigenetik bir hastalıktır ve dünya çapında kanser sebepli ölümler arasında üçüncü sıradadır. Hepatokarsinogenez oldukça kompleks ve çok aşamalı bir süreçten oluşmaktadır. Epigenetik değişiklikler, anormal DNA metilasyonu, posttranslasyonel histon modifikasyonları, anormal kodlanmayan RNA miRNA, lnc-RNA gibi ekspresyonu ve kromatinin yeniden modellenmesini içermektedir. Bu mekanizmalar kanser gelişiminde onkogenlerin, tümör baskılayıcı genlerin ve diğer tümörle ilişkili genlerin ekspresyonunu ve yolakların değişimini doğrudan etkilemektedir. Pek çok kompleks miRNA, lnc-RNA uzun kodlanmayan RNA ve piRNA PIWI proteini ile ilişkili RNA regülasyon bozukluğu tümör baskılayıcı genleri hedef alarak dramatik bir şekilde hepatokarsinogeneze dahil olmaktadır. Ayrıca bu genlerin promotör hipermetilasyonu ya da posttranslasyonel regülasyon bozuklukları sebebiyle ekspresyonları azalmaktadır. Hepatokarsinogezde rol alan bu epigenetik mekanizmalar HCC için yeni terapötik yaklaşımlar sunmaktadır. Bu derlemede; hepatosellüler karsinoma oluşumunda etkili epigenetik mekanizmalar konusundaki güncel çalışmaların sonuçları özetlenmiştir.

🔖

Cite This Article

DOĞAN, R., AKTAŞ, R. G. (2016). Epigenetic Mechanisms and Hepatocellular Carcinoma. Maltepe Tıp Dergisi, Cilt: 8 - Sayı: 3, 29–35. https://ajindex.com/articles/230905

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999;353:1253–1257.
  2. Center MM, Jemal A. International trends in liver can- cer incidence rates. Cancer Epidemiol Biomarkers Prev 2011;20:2362–2368
  3. Herath N.I, Leggett B.A, MacDonald G.A. Review of ge- netic and epigenetic alterations in hepatocarcinogene- sis, J. Gastroenterol. Hepatol. 2006;15–21.
  4. Vaissiere T, Sawan C, Herceg Z. Epigenetic interplay be- tween histone modifications and DNA methylation in gene silencing, Mutat. Res. 2008;659:40–48.
  5. Frau M, Feo F.C, Feo F, Pascale R.M. New insights on the role of epigenetic alterations in hepatocellular carcino- ma. Journal of Hepatocellular Carcinoma 2014;1:65– 83. You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 2012;22:9-20.
  6. Calvisi D.F, Ladu S, Gorden A, Farina M, Lee J.S, Conner E.A, Schroeder I, Factor V.M, Thorgeirsson S.S. Mecha- nistic and prognostic significance of aberrant methyla- tion in the molecular pathogenesis of human hepatocel- lular carcinoma, J. Clin. Invest. 2007;117:2713–2722.
  7. Libbrecht L, Desmet V, Roskams T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int 2005;25:16– 27. Bird AP. The relationship of DNA methylation to cancer. Cancer Surv. 1996;28:87–101.
  8. Bestor TH, Ingram VM. Two DNA methyltransferases from murine erythroleukemia cells: purification, se- quence specificity, and mode of interaction with DNA. Proc Natl Acad Sci U S A. 1983;80(18):5559–5563.
  9. Okano M, Bell DW, Haber DA, Li E. DNA methyltrans- ferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247–257.
  10. Bell AC, Felsenfeld G. Methylation of a CTCF-depend- ent boundary controls imprinted expression of the Igf2 gene. Nature. 2000;405(6785):482–485. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem. 1990;1(5):228–237.
  11. Pascale RM, Simile MM, De Miglio MR. Chemopreven- tion by S-adenosyl-L-methionine of rat liver carcinogen- esis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. Carcinogenesis. 1995;16(2):427–430.
  12. Lu SC, Mato JM. Role of methionine adenosyltrans- ferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol. 2005;35(3):227–234.
  13. Yang B, Guo M, Herman JG, Clark DP. Aberrant promot- er methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 2003;163:1101– 1107. Jicai Z, Zongtao Y, Jun L, Haiping L, Jianmin W, Lihua H. Persistent infection of hepatitis B virus is involved i